Incidence, Risk Factor, Treatment and Overall Survival of Locally Recurrent Rectal Cancer
NCT ID: NCT05475301
Last Updated: 2023-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1431 participants
OBSERVATIONAL
2015-01-01
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer
NCT00016250
A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
NCT06637462
Mesalazine Effects in Sporadic Colorectal Adenoma Patients
NCT01894685
Tumor Recurrence After Abdominal-perineal Amputation in Squamous Cell Carcinoma of the Anus
NCT05201105
Multiparametric Characterization of Colorectal Cancers (METRAD)
NCT07000474
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed between January 1st and June 30th of 2015;
* TME resection of primary rectal carcinoma.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Radboud University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hidde Swartjes
Researcher in training
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K20.256
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.